Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences, a biotechnology company specializing in tissue regeneration, has initiated a preclinical development program for its B.R.E.A.S.T.™ (BioRegenerative Ergonomically Architected Smart Tissue) platform at the Wake Forest Institute for Regenerative Medicine (WFIRM). The program will assess the durability, host tissue integration, and resorbability of Conexeu’s proprietary CXU™ 3D-printed matrix technology, using WFIRM’s advanced bioprinting infrastructure. The B.R.E.A.S.T.™ matrix is designed as a resorbable and bioregenerative alternative to permanent breast implants, guiding a patient’s own cells to form new tissue. This approach aims to address limitations of traditional implant technologies. The study will leverage the Integrated Tissue-Organ Printing System (iTOPS) at WFIRM, supported by the RegenMed Development Organization (ReMDO), to accelerate the translation of the technology toward clinical applications. Miles Harrison, President and CEO of Conexeu, stated that the preclinical program marks a key step in advancing B.R.E.A.S.T.™ and the company’s regenerative medicine strategy. He emphasized the potential of bioregenerative approaches to surpass traditional implant methods. Dr. Claudia Chavez-Munoz, Chief Scientific Officer and co-founder of Conexeu, highlighted the importance of rigorous research in defining the biological performance and scalability of the technology. ReMDO’s support provides Conexeu with access to advanced bioprinting tools, de-risking innovation and facilitating scalable biomanufacturing. Joshua Hunsberger, PhD, Chief Technology Officer at ReMDO, noted that Conexeu’s progress exemplifies the organization’s mission to accelerate regenerative medicine technologies. The collaboration aims to bring the B.R.E.A.S.T.™ platform closer to clinical development, offering a potential breakthrough in soft tissue restoration.